Growing Demand Prompts LENSAR to Expand Sales Force, Expand Global Distribution for Its Cataract Surgery Laser

ORLANDO, FL--(Marketwired - Aug 5, 2013) - LENSAR Inc., developer of the next generation LENSAR™ Laser System for refractive cataract surgery, announced today it is significantly expanding its sales force and global distribution to better handle increasing demand.

"The response we're seeing from cataract surgeons is gratifying," said Nick Curtis, LENSAR's Chief Executive Officer. "The LENSAR Laser System is taking cataract surgery to the next level with optimal clinical outcomes, and we're responding by expanding our commercial presence and distribution to meet demand."

Surgeons worldwide are responding to the intelligence and superior imaging of the LENSAR Laser System, reporting that it has redefined safety and enabled them to handle even the most difficult cataract cases with peace of mind. This confidence is thanks to LENSAR's Augmented Reality technology, which provides exact biometric data points of each patient's eye to create a 3-D model of the anterior anatomy, so that every laser pulse can be precisely placed. Like a CAT scan, LENSAR's Augmented Reality's imaging system rotates while scanning the eye to identify all ocular structures with unsurpassed clarity and accuracy.

"LENSAR is an exceptionally advanced platform for bladeless cataract surgery and is achieving consistent, predictable outcomes," said Dr. Louis "Skip" Nichamin, a member of LENSAR's medical advisory board. "This technology is truly a key advance."

The LENSAR Laser System gives cataract surgeons the power to execute accurate incisions with unprecedented precision and repeatability. It provides precise capsulotomy incision size, shape and location, thereby enhancing effective IOL lens positioning and fitting for each individual patient, leading to improved patient outcomes.

With the expanded sales force and distribution channels, LENSAR is preparing the company to handle significant growth in seven countries worldwide.

About LENSAR, Inc.
LENSAR, Inc. is a leader in the development and commercialization of next-generation laser and advanced imaging, measurement and 3-D modeling technology for refractive cataract surgery.

The LENSAR Laser System is U.S. Food and Drug Administration 510(k) cleared and CE mark approved for performing anterior capsulotomy, laser phacofragmentation, and the creation of full and partial thickness single-plane and multi-plane arc cuts/incisions in the cornea during cataract surgery for removal of the crystalline lens. For more information please visit www.LENSAR.com.